The DOI matches its Crossref record.
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review
Abstract
INTRODUCTION: Urease is the enzyme that catalyzes the hydrolysis of urea, which is involved in serious infections caused by Helicobacter pylori in the gastric tract, as well as Proteus and related species in the urinary tract. The necessity to treat such infections has stimulated intensive studies on various groups of urease inhibitors. AREAS COVERED: Patent literature on urease inhibitors with possible applications in medicine is reviewed in this paper. Hydroxamic acids, phosphoramidates, urea derivatives, quinones and heterocyclic compounds constitute the major classes of structures with such activity. EXPERT OPINION: Until now, only one compound, acetohydroxamic acid, has been clinically used for the treatment of urinary tract infections by urease inhibition. Unfortunately, it exhibits severe side effects. Thus, it seems that the full potential of urease inhibition has not yet been fully explored. Several Japanese patents related to the use of herbal extracts as sources of polyphenolic urease inhibitors have been considered as complementary or alternative therapy; however, their accessibility is quite possibly due to reduced restrictions for the introduction of natural products to the market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
Mucha, A., Kafarski, P., & Berlicki, Ł. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200587f · Cited by 672
Self-citationSchiff bases in medicinal chemistry: a patent review (2010-2015)
Hameed, A., al-Rashida, M., Uroos, M., Abid Ali, S., & Khan, K. M. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1252752 · Cited by 401
Urease-aided calcium carbonate mineralization for engineering applications: A review
Krajewska, B. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2017.10.009 · Cited by 327
Ureases: Historical aspects, catalytic, and non-catalytic properties – A review
Kappaun, K., Piovesan, A. R., Carlini, C. R., & Ligabue-Braun, R. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.05.010 · Cited by 269
Metadata
- Authors
- Kosikowska, P., & Berlicki, Ł.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa UK Limited
- Published
- 2011-04-04
- Volume
- 21
- Issue
- 6
- Pages
- 945-957
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W2095041765
- Cited by
- 199
- References
- 0
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. https://app.cochat.ai/papers/10.1517/13543776.2011.574615
- The paper
- Kosikowska, P., & Berlicki, Ł. (2011). Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.2011.574615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.